Agilon Health, Inc.
AGL Healthcare Medical Care Facilities
Agilon Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.9 billion, down 2.11% from fiscal 2024. In the quarter to June 2026, revenue grew 7.15%, EPS grew 117.1%, free cash flow fell 50.2% and total debt fell 13.3%, each against the same quarter a year earlier. Dividend growth for five consecutive years; insiders bought in the last twelve months.
Follow AGL
Agilon Health, Inc. (AGL) EV/Sales
As of 16 October 2026, Agilon Health, Inc. (AGL) trades at a EV/Sales of 0.2×. Over the past ten years it has ranged from 0.0× (March 2026) to 10.5× (June 2021); the current reading is higher than 28% of that period. That is below the Medical Care Facilities industry median of 1.3× and below the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 0.0× | (91.46%) |
| FY2024 | 0.1× | (93.83%) |
| FY2023 | 1.1× | (53.13%) |
| FY2022 | 2.4× | (61.11%) |
| FY2022 | 6.1× | 3.09% |
| FY2021 | 6.0× | (20.78%) |
| FY2021 | 7.5× | 0.00% |
| FY2020 | 7.5× | 0.00% |
| FY2020 | 7.5× | 0.00% |
| FY2019 | 7.5× | 0.00% |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 0.3× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | (81.33%) |
| Sep 2025 | 0.0× | (73.15%) |
| 22 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| CMPS COMPASS Pathways PLC Sponsored ADR compare | n/m |
| AGL Agilon Health, Inc. | 0.2× |
| ARDT Ardent Health, Inc. compare | 0.3× |
| AMN AMN Healthcare Services Inc compare | 0.6× |
| HCSG Healthcare Services Group, Inc. compare | 0.7× |
| PNTG The Pennant Group, Inc. compare | 1.5× |
| NUTX Nutex Health Inc. compare | 1.6× |
| USPH U.S. Physical Therapy, Inc. compare | 1.8× |
| SNDA Sonida Senior Living, Inc. compare | 6.0× |
| Medical Care Facilities industry median | 1.3× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)